Sutro Biopharma Inc banner

Sutro Biopharma Inc
F:S09

Watchlist Manager
Sutro Biopharma Inc Logo
Sutro Biopharma Inc
F:S09
Watchlist
Price: 12.5 EUR -5.3% Market Closed
Market Cap: €1B

Wall St Price Targets

S09 Price Targets Summary
Sutro Biopharma Inc

Wall Street analysts forecast S09 stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for S09 is 1.41 EUR with a low forecast of 0.29 EUR and a high forecast of 1.85 EUR.

Lowest Forecast
Price Target
0.29 EUR
98% Downside
Average Forecast
Price Target
1.41 EUR
89% Downside
Highest Forecast
Price Target
1.85 EUR
85% Downside
Sutro Biopharma Inc Competitors:
Price Targets
CSGP
CoStar Group Inc
66% Upside
VAC
Pierre et Vacances SA
23% Upside
MEDP
Medpace Holdings Inc
-21% Downside
LVO
LiveOne Inc
165% Upside

Revenue
Forecast

9% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
9% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 8 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 20%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is S09's stock price target?
Price Target
1.41 EUR

According to Wall Street analysts, the average 1-year price target for S09 is 1.41 EUR with a low forecast of 0.29 EUR and a high forecast of 1.85 EUR.

What is the Revenue forecast for Sutro Biopharma Inc?
Projected CAGR
20%

Over the last 8 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 20%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett